...Changing The World

Human Vaccines Project.

Human Vaccines Project

The Human Vaccines Project [HVP] is a global nonprofit that brings together leading stakeholders across academia, industry, governments and nonprofits. Their mission is to accelerate the development of vaccinations and immunotherapies against major global infectious diseases and cancers by focusing on the pre-competitive immunology research space and decoding the human immune system.

It was established in February 2014, when 35 leading global scientists from the public and private sectors came together to discuss the potential of technological advances in genomics, bioinformatics and systems biology as well as how to overcome impediments in the development of new vaccinations.

Human Vaccines Project • 2 Programs

The Human Vaccines Project scientific plan is made up of two complementary and integrated programs:

  1. The Human Immunome Program focused on defining the parts or components of the immune system, led by Dr. James Crowe, Director of the Vanderbilt University Vaccine Center.
  2. The Rules of Immunity Program seeking to define the rules of immunological protection, led by Dr. Wayne C. Koff, CEO of the Human Vaccines Project.

Rapid innovations in genomics, bioinformatics and artificial intelligence are revolutionizing biomedical research and making reality advances not thought possible even five years ago. The Human Vaccines Project puts these technologies in the hands of the world’s top scientists by bringing together some of the world’s leading universities, companies and nonprofits under a coordinated effort to decode the human immune system and transform how we prevent and treat disease.

James Crowe, Human Immunome Program; Director of the Vanderbilt University Vaccine Center. (Credit: Vanderbilt University Medical Center)The Human Immunome Program is led by Dr. James Crowe, Director of the Vanderbilt University Vaccine Center. (Credit: Vanderbilt University Medical Center)

The Rules of Immunity Program program is currently led by Dr. Wayne C. Koff, CEO of the Human Vaccines Project. (Credit: The Human Vaccines Project)The Rules of Immunity Program program is currently led by Dr. Wayne C. Koff, CEO of the Human Vaccines Project. (Credit: The Human Vaccines Project)

MMRF Library

MMRF Initiative

Human Vaccines Project Initiative

The Human Vaccines Project: How We Treat and Prevent Diseases [2017-09-16. HVP/Theodore Schenkelberg]

Gary Karlin Michelson, M.D. and Alya Michelson from the Michelson Medical Research Foundation are proud sponsors of the Michelson Prizes for Human Immunology and Vaccine Research, in partnership with the Human Vaccines Project, which supports young investigators applying innovative research concepts and disruptive technologies to defeat major global diseases by significantly advancing the development of future vaccines and therapies.

Gary Karlin Michelson, M.D. and Alya Michelson from the Michelson Medical Research Foundation are proud sponsors of the Michelson Prizes for Human Immunology and Vaccine Research, in partnership with the Human Vaccines Project, which supports young investigators applying innovative research concepts and disruptive technologies to defeat major global diseases by significantly advancing the development of future vaccines and therapies.

Gary Karlin Michelson, M.D. and Alya Michelson from the Michelson Medical Research Foundation are proud sponsors of the Michelson Prizes for Human Immunology and Vaccine Research, in partnership with the Human Vaccines Project, which supports young investigators applying innovative research concepts and disruptive technologies to defeat major global diseases by significantly advancing the development of future vaccines and therapies.

Gary Karlin Michelson, M.D. and Alya Michelson from the Michelson Medical Research Foundation are proud sponsors of the Michelson Prizes for Human Immunology and Vaccine Research, in partnership with the Human Vaccines Project, which supports young investigators applying innovative research concepts and disruptive technologies to defeat major global diseases by significantly advancing the development of future vaccines and therapies.

Back to Top